J0565 HCPCS code: Injection, bezlotoxumab, 10 mg
J0565 is the HCPCS Level II code for injection, bezlotoxumab, 10 mg. In 2024 Medicare paid an average of $31.11 per service for J0565 across 53,239 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 200 per day on outpatient hospital claims. Medicare volume fell 17% from 2022 to 2024 (63,830 to 53,239 services). In 2024, about 325 clinicians billed Medicare for J0565 for 522 beneficiaries; Florida, Texas, California accounted for 44% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2018-01-01 |
| Last action effective | 2018-01-01 |
Who bills J0565 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 325 |
| Medicare beneficiaries | 522 |
| States with claims | 18 |
| Share of services in top 3 states (Florida, Texas, California) | 44% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J0565, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 63,830 | 640 | $39.10 | $31.16 |
| 2023 | 57,474 | 567 | $38.89 | $30.95 |
| 2024 | 53,239 | 522 | $39.08 | $31.11 |
States with the most J0565 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Florida | 9,004 | $31.26 |
| Texas | 6,937 | $30.83 |
| California | 3,776 | $31.20 |
| New Jersey | 3,190 | $31.19 |
| Illinois | 2,401 | $31.13 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 200 | Prescribing Information |
| practitioner claims | 200 | Prescribing Information |
What changed for J0565
- 2018-01-01: J0565 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J0565?
J0565 is the HCPCS Level II code for injection, bezlotoxumab, 10 mg. Short descriptor: "Inj, bezlotoxumab, 10 mg".
How much does Medicare pay for J0565?
In 2024, the average Medicare payment was $31.11 per service (average allowed $39.08).
Does Medicare cover J0565?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J0565 can be billed per day?
200 on outpatient hospital claims; 200 on practitioner claims (NCCI medically unlikely edits).
Related J05 codes
- J0500 — Injection, dicyclomine hcl, up to 20 mg
- J0515 — Injection, benztropine mesylate, per 1 mg
- J0517 — Injection, benralizumab, 1 mg
- J0520 — Injection, bethanechol chloride, myotonachol or urecholine, up to 5 mg
- J0525 — Injection, cefotetan disodium, 10 mg
- J0528 — Injection, fosfomycin disodium, 20 mg
- J0558 — Injection, penicillin g benzathine and penicillin g procaine, 100,000 units
- J0561 — Injection, penicillin g benzathine, 100,000 units
- J0567 — Injection, cerliponase alfa, 1 mg
- J0570 — Buprenorphine implant, 74.2 mg
- J0571 — Buprenorphine, oral, 1 mg
- J0572 — Buprenorphine/naloxone, oral, less than or equal to 3 mg buprenorphine
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J0565
- Watch J0565 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J0565
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.